Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{{familytree | | | | | | | | | |!| | | | | | | | }} | {{familytree | | | | | | | | | |!| | | | | | | | }} | ||
{{familytree | | | | | | | | | C01 | | | | | |C01=Histopathologic examination}} | {{familytree | | | | | | | | | C01 | | | | | |C01=Histopathologic examination}} | ||
{{familytree | | |,|-|-|-|-|-|-| | {{familytree | | |,|-|-|-|-|-|-|^|v|-|-|-|-|-|.| }} | ||
{{familytree | |D01| | | | | |D02 | {{familytree | |D01| | | | | | |D02| | | D03 |D01='''Squamous cell carcinoma'''|D02='''Neuroendocrine carcinoma'''|D03='''Adenocarcinoma and poorly differntiated carcinoma'''}} | ||
{{familytree | | |!| | | | | | | |!| | | | | |!| }} | {{familytree | | |!| | | | | | | |!| | | | | |!| }} | ||
{{familytree | |E01| | | | | |E02 | | | |E03| |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}} | {{familytree | |E01| | | | | |E02 | | | |E03| |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}} | ||
Revision as of 19:02, 10 October 2018
| Tumor of unknown primary origin | |||||||||||||||||||||||||||||||||||||
| • Full medical history and physical exam • Basic blood and bichemical analysis • CT scan of chest, abdomen, and pelvis | |||||||||||||||||||||||||||||||||||||
| Histopathologic examination | |||||||||||||||||||||||||||||||||||||
| Squamous cell carcinoma | Neuroendocrine carcinoma | Adenocarcinoma and poorly differntiated carcinoma | |||||||||||||||||||||||||||||||||||
| Additional tests specific to location of metastasis | • Octreoscan • Plasma chromogranin A | Gender specific tests | |||||||||||||||||||||||||||||||||||
| bone | Ing | Supra | |||||||||||||||||||||||||||||||||||